Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review

BACKGROUND: Osteosarcoma is the most common bone tumor in children and adolescents. Despite multiagent chemotherapy, only 71% of patients survives and these survivors often experience long-term toxicities. The main objective of this systematic review is to provide an overview of the discovery of nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurkmans, Evelien G. E., Brand, Annouk C. A. M., Verdonschot, Job A. J., te Loo, D. Maroeska W. M., Coenen, Marieke J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761983/
https://www.ncbi.nlm.nih.gov/pubmed/36536332
http://dx.doi.org/10.1186/s12885-022-10434-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761983/
https://www.ncbi.nlm.nih.gov/pubmed/36536332
http://dx.doi.org/10.1186/s12885-022-10434-5

Ejemplares similares